Search results
mRNA Vaccines. With India’s first and the World’s third mRNA vaccine, Gennova ushers in a future. where emerging diseases can be met with speed, precision and unparalleled. efficacy. Our mRNA vaccine is the first mRNA vaccine to be stable at 2 to 8˚ C, addressing the unmet need globally.
Gennova Biopharmaceuticals Ltd ., headquartered in Pune, India, is a biotechnology company dedicated to developing, producing, and commercializing biotherapeutics to address life-threatening diseases across various indications.
Gennova Biopharmaceuticals Ltd., headquartered in Pune, India, is a biotechnology company dedicated to the research, development, production, and commercialization of bio-therapeutics and...
Jul 12, 2022 · Gennova Biopharmaceuticals has become India's first mRNA Covid-19 vaccine maker. Does it have any relevance now though? Gemcovac-19 is built on a platform that can be tweaked to make vaccines...
Genova Biopharmaceuticals mRNA COVID-19 vaccine receives EUA from DCGI. GEMCOVAC-19 is the very first mRNA vaccine developed in India and only third mRNA vaccine to be approved for COVID-19 in the world.
Jun 28, 2022 · The country’s first homegrown mRNA Covid-19 vaccine developed at Pune’s Gennova Biopharmaceuticals has received emergency use for the age group 18 and above. In a late-night development, the Drug Controller General of India (DCGI) approved the two-dose mRNA vaccine on Tuesday.
Mar 11, 2022 · Gennova Biopharmaceuticals has presented data from human trials of its mRNA Covid-19 vaccine to India's drug regulatory authority for evaluation, people in the know said. Pune-based Gennova is developing the country's first indigenously developed mRNA vaccine for Covid-19.
